Dixon J F, Hokin L E
Department of Pharmacology, University of Wisconsin Medical School, Madison 53706.
Biochem J. 1994 Nov 15;304 ( Pt 1)(Pt 1):251-8. doi: 10.1042/bj3040251.
Previous studies showed that lithium, beginning at therapeutic plasma concentrations in the treatment of manic depression, increased the accumulation of second-messenger inositol 1,4,5-trisphosphate [Ins(1,4,5)P3] in cerebral cortex slices of guinea pig and rhesus monkey [Lee, Dixon, Reichman, Moummi, Los and Hokin (1992) Biochem. J. 282, 377-385; Dixon, Lee, Los and Hokin (1992) J. Neurochem. 59, 2332-2335; Dixon, Los and Hokin (1994) Proc. Natl. Acad. Sci. U.S.A. 91, 8358-8362]. These studies have now been extended to a peripheral tissue, mouse pancreatic minilobules. In the presence of carbachol, concentrations of lithium from 1 to 20 mM sharply and progressively increased the accumulation of Ins(1,4,5)P3 and inositol 1,3,4,5-tetrakisphosphate, followed by a decrease. Assay of these inositol polyphosphates by either the prelabelling technique or mass assay gave similar results. Atropine quenching of cholinergically stimulated pancreatic minilobules led to a rapid disappearance of Ins(1,4,5)P3. This disappearance was impeded by lithium. This suggested that the lithium-induced elevation in Ins(1,4,5)P3 was due to inhibition of the 5-phosphatase and, on the basis of the markedly elevated concentrations of inositol 1,3,4-trisphosphate [Ins(1,3,4)P3] and inositol 1,4-bisphosphate in the presence of lithium, probably by feedback inhibition by these latter two compounds. An additional mechanism, i.e. a stimulatory effect of lithium on phospholipase C, cannot, however, be ruled out. The other reaction product of phospholipase C, inositol cyclic 1:2,4,5-trisphosphate, also increased in the presence of lithium. This may also be due to inhibition of the 5-phosphatase, which is the exclusive mechanism for removal of this compound. The effects of lithium on the accumulation of other inositol phosphates paralleled that of Ins(1,4,5)P3, with the exception of inositol 3,4-bisphosphate, which decreased. This was presumably due to the inhibition of Ins(1,3,4)P3 1-phosphatase by lithium. Unlike mouse cerebral cortex slices [Lee, Dixon, Reichman, Moummi, Los and Hokin (1992) Biochem. J. 282, 377-385], inositol supplementation was not required to demonstrate lithium-stimulated Ins(1,4,5)P3 accumulation in mouse pancreatic minilobules. This indicates that inositol depletion sufficient to impair lithium-stimulated Ins(1,4,5)P3 accumulation does not occur in mouse pancreatic minilobules, even though an elevation of cytidine diphosphodiacylglycerol occurred, indicating some inositol depletion due to lithium. Elevation of Ins(1,4,5)P3 by lithium may be a general phenomenon in the central nervous system and peripheral tissues under non-rate-limiting concentrations of inositol.
以往的研究表明,锂在治疗躁狂抑郁症时,从治疗性血浆浓度开始,会增加豚鼠和恒河猴大脑皮层切片中第二信使肌醇1,4,5 -三磷酸[Ins(1,4,5)P3]的积累[Lee, Dixon, Reichman, Moummi, Los和Hokin(1992)《生物化学杂志》282, 377 - 385; Dixon, Lee, Los和Hokin(1992)《神经化学杂志》59, 2332 - 2335; Dixon, Los和Hokin(1994)《美国国家科学院院刊》91, 8358 - 8362]。这些研究现已扩展到外周组织——小鼠胰腺小叶。在卡巴胆碱存在的情况下,1至20 mM的锂浓度会急剧且逐渐增加Ins(1,4,5)P3和肌醇1,3,4,5 -四磷酸的积累,随后下降。通过预标记技术或质量测定法对这些肌醇多磷酸进行测定得到了相似的结果。用阿托品淬灭经胆碱能刺激的胰腺小叶会导致Ins(1,4,5)P3迅速消失。锂会阻碍这种消失。这表明锂诱导的Ins(1,4,5)P3升高是由于对5 -磷酸酶的抑制,并且基于在锂存在下肌醇1,3,4 -三磷酸[Ins(1,3,4)P3]和肌醇1,4 -二磷酸的浓度显著升高,可能是由后两种化合物的反馈抑制所致。然而,不能排除锂对磷脂酶C的刺激作用这一额外机制。磷脂酶C的另一种反应产物肌醇环1:2,4,5 -三磷酸在锂存在时也会增加。这也可能是由于对5 -磷酸酶的抑制,这是去除该化合物的唯一机制。锂对其他肌醇磷酸积累的影响与Ins(1,4,5)P3相似,但肌醇3,4 -二磷酸除外,其含量下降。这可能是由于锂抑制了Ins(1,3,4)P3 1 -磷酸酶。与小鼠大脑皮层切片不同[Lee, Dixon, Reichman, Moummi, Los和Hokin(1992)《生物化学杂志》282, 377 - 385],在小鼠胰腺小叶中证明锂刺激的Ins(1,4,5)P3积累不需要补充肌醇。这表明在小鼠胰腺小叶中不会发生足以损害锂刺激的Ins(1,4,5)P3积累的肌醇耗竭,尽管胞苷二磷酸二酰甘油升高,表明锂导致了一些肌醇耗竭。在肌醇非限速浓度下,锂引起的Ins(1,4,5)P3升高可能是中枢神经系统和外周组织中的普遍现象。